EMA must release adverse reaction reports from trials, says Ombudsman

摘要

The EMA has come under pressure from the European Ombudsman to release information on adverse reactions to drugs in trials. Nikiforos Diamandouros said EU rules on releasing information associated with its decision-making apply to all documents held by EMA.